Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Efudix Ointment*


Contraindicated
Absolute contraindication

Contraindicated
Absolute contraindication
Efudix Ointment* :
Type Medicine Non Marketed
Originator B
Agent Omnipharma
Distributor Omnipharma
Laboratory Meda Pharmaceuticals
Responsible Party Valeant Pharmaceuticals Switzerland GmbH
Origin Switzerland
Manufacturer Valeant Pharmaceuticals Switzerland GmbH
Origin Switzerland
ATC L01BC02

Your comment will appear shortly after approval

Efudix Ointment* :

Revision Date : 01/02/2015


Effect Frequency
Abdominal pain Very rare
Allergic reaction Very rare
Alopecia Very rare
Application site vesicles Very rare
Burn Very rare
Chills Very rare
Conjunctivitis Not known
Dermatitis Very rare
Dermatitis contact Very rare
Diarrhoea (Diarrhea) Very rare
Diarrhoea haemorrhagic Very rare
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Not known
Eczema Very rare
Erythema Very rare
Erythema multiforme Very rare
Fever Very rare
Keratitis Not known
Lacrimation Not known
Leukocytosis Very rare
Mucositis Not known
Neutropenia Very rare
Oedema Not known
Pancytopenia Very rare
Photosensitivity reaction Very rare
Pruritus Very rare
Skin Eruption Very rare
Skin exfoliation (Flaking skin) Very rare
Skin flushed Uncommon
Skin irritation Very rare
Skin reaction Very rare
Skin soreness Very rare
Skin ulcer Very rare
Stomatitis Very rare
Swelling Very rare
Thrombocytopenia (Thrombopenia) Very rare
Type IV hypersensitivity reaction Very rare
Urticaria Very rare
Vomiting Very rare

Different Units By MoH Code

Revision Date : 01/03/2006

Efudix Ointment*  MoH 1714 :
Form Cutaneous ointment
Packaging Tube
Package Size 20g
Strength 5%
NSSF ✘
Quarantine ✘
Reg. Number 208039/03
Submission date 01/01/2003
Registration Year 2003
Archived Date 2014


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info